Although anti-CTLA-4 alpaca heavy chain-only Fab could sufficiently block CD80/86-CTLA-4 interactions and localize in B16-F10 melanoma tumors, it did not reduce tumor burden or deplete intra-tumoral Tregs. Here, CTLA4 is linked to neoplasm.